Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
ABSTRACTInflammatory bowel disease (IBD) is a chronic, recurrent inflammatory disease of the gastrointestinal tract. In addition to digestive symptoms, patients with IBD may also develop extra-intestinal manifestations (EIMs), the etiology of which remains undefined. The gut microbiota has been repo...
Main Authors: | Yizhe Tie, Yongle Huang, Rirong Chen, Li Li, Minhu Chen, Shenghong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2023.2265028 |
Similar Items
-
Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease
by: María Hernández-Tejero, et al. -
Exploring the intestinal ecosystem: from gut microbiota to associations with subtypes of inflammatory bowel disease
by: Fan Li, et al.
Published: (2024-01-01) -
Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era
by: Alix Cuny, et al.
Published: (2022-08-01) -
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study
by: Francesca Ferretti, et al.
Published: (2022-08-01) -
Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease
by: Sandra Hertz, et al.
Published: (2024-12-01)